Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1591-1600 of 1,779) with videos related to

Pageof 178
Sort By:
Mabs|November 2, 2020
Isolation of monoclonal antibodies from anti-synthetase syndrome patients and affinity maturation by recombination of independent somatic variantsLuke Burman, Yeeting E Chong, Sherie Duncan, et al.
Mabs|January 27, 2021
Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysisHsueh-Yuan Chang, Shengjia Wu, Yingyi Li, et al.
Mabs|January 15, 2021
Ab-Ligity: identifying sequence-dissimilar antibodies that bind to the same epitopeWing Ki Wong, Sarah A Robinson, Alexander Bujotzek, et al.
Mabs|November 12, 2021
Impact of IgG subclass on molecular properties of monoclonal antibodiesYu Tang, Paul Cain, Victor Anguiano, et al.
Mabs|March 23, 2021
A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3Alexander Rau, Katharina Kocher, Mirjam Rommel, et al.
Mabs|December 20, 2021
Assay format diversity in pre-clinical immunogenicity risk assessment: Toward a possible harmonization of antigenicity assaysAxel Ducret, Chloé Ackaert, Juliana Bessa, et al.
Mabs|December 20, 2021
Phenotypic whole-cell screening identifies a protective carbohydrate epitope on <i>Klebsiella pneumoniae</i>Sophia K Berry, Steven Rust, Carolina Caceres, et al.
Mabs|December 20, 2021
Development of a nonhuman primate challenge model to evaluate CD8<sup>+</sup> T cell responses to an adenovirus-based vaccine expressing SIV proteins upon repeat-dose treatment with checkpoint inhibitorsRichard Graveline, Morad Haida, Carolyne Dumont, et al.
Mabs|January 10, 2022
Harnessing the potential of machine learning for advancing "Quality by Design" in biomanufacturingIan Walsh, Matthew Myint, Terry Nguyen-Khuong, et al.
Mabs|January 3, 2022
Non-targeted characterization of attributes affecting antibody-FcγRIIIa V158 (CD16a) binding via online affinity chromatography-mass spectrometryDaniel W Woodall, Thomas M Dillon, Kevin Kalenian, et al.
Pageof 178

Showing results (1591-1600 of 1,779) with videos related to

Sort By:
Pageof 178
Mabs|November 2, 2020
Isolation of monoclonal antibodies from anti-synthetase syndrome patients and affinity maturation by recombination of independent somatic variantsLuke Burman, Yeeting E Chong, Sherie Duncan, et al.
Mabs|January 27, 2021
Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysisHsueh-Yuan Chang, Shengjia Wu, Yingyi Li, et al.
Mabs|January 15, 2021
Ab-Ligity: identifying sequence-dissimilar antibodies that bind to the same epitopeWing Ki Wong, Sarah A Robinson, Alexander Bujotzek, et al.
Mabs|November 12, 2021
Impact of IgG subclass on molecular properties of monoclonal antibodiesYu Tang, Paul Cain, Victor Anguiano, et al.
Mabs|March 23, 2021
A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3Alexander Rau, Katharina Kocher, Mirjam Rommel, et al.
Mabs|December 20, 2021
Assay format diversity in pre-clinical immunogenicity risk assessment: Toward a possible harmonization of antigenicity assaysAxel Ducret, Chloé Ackaert, Juliana Bessa, et al.
Mabs|December 20, 2021
Phenotypic whole-cell screening identifies a protective carbohydrate epitope on <i>Klebsiella pneumoniae</i>Sophia K Berry, Steven Rust, Carolina Caceres, et al.
Mabs|December 20, 2021
Development of a nonhuman primate challenge model to evaluate CD8<sup>+</sup> T cell responses to an adenovirus-based vaccine expressing SIV proteins upon repeat-dose treatment with checkpoint inhibitorsRichard Graveline, Morad Haida, Carolyne Dumont, et al.
Mabs|January 10, 2022
Harnessing the potential of machine learning for advancing "Quality by Design" in biomanufacturingIan Walsh, Matthew Myint, Terry Nguyen-Khuong, et al.
Mabs|January 3, 2022
Non-targeted characterization of attributes affecting antibody-FcγRIIIa V158 (CD16a) binding via online affinity chromatography-mass spectrometryDaniel W Woodall, Thomas M Dillon, Kevin Kalenian, et al.
Pageof 178